A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life.
Information source: Pfizer
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Exudative Age-related Macular Degeneration
Intervention: Macugen (Drug)
Phase: N/A
Status: Completed
Sponsored by: Pfizer Official(s) and/or principal investigator(s): Pfizer CT.gov Call Center, Study Director, Affiliation: Pfizer
Summary
To assess effectiveness of Macugen for treatment of neovascular age-related macular
degeneration by measuring the evolution of visual acuity. Treatment duration, frequency of
administration and combination with other treatments will also be evaluated.
Clinical Details
Official title: A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration (AMD) In Real Life (Macureli Study).
Study design: Observational Model: Cohort
Primary outcome: Change From Baseline to Final Visit in Visual Acuity (VA) Score
Secondary outcome: Number of Participants With Change in VA: ImprovementNumber of Participants With Change in VA: Stabilization Number of Participants With Change in VA: Worsening Duration of Treatment Frequency of Macugen Administration Number of Participants Who Received Other Concomitant Age Related Macular Degeneration (AMD) Treatments
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients diagnosed with subfoveal neovascular (wet) age-related macular degeneration
- Patients having received at least 1 Macugen injection
- Treatment naive patients, or patients having received conventional therapy
- Patients having signed and dated informed consent.
Exclusion Criteria:
- Patients participating in another clinical study with Macugen.
Locations and Contacts
Pfizer Investigational Site, Aarschot 3200, Belgium
Pfizer Investigational Site, Deurne 2100, Belgium
Pfizer Investigational Site, Leuven 3000, Belgium
Pfizer Investigational Site, Liege 4000, Belgium
Additional Information
To obtain contact information for a study center near you, click here.
Starting date: November 2007
Last updated: February 15, 2011
|